États-Unis Healthcare Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de États-Unis Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 2,070 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals & Medical Research Mega (1.1tn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mega (614.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (443.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (345.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (333.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (230.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (221.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (188.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (171.6bn) 0 Aucune activité — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (155.3bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (143.8bn) 0 Aucune activité — 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (140.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (137.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (132.4bn) 0 Aucune activité — 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (127.2bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (119.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (111.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (96.7bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (83.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (81.9bn) 0 $1M–$10M 0–15% 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Aucune activité — —
Healthcare Services Large (72.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (69.5bn) 1–5 $1M–$10M 0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Aucune activité — 0–15%
US Cencora Inc (COR)
Healthcare Services Large (61.7bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (53.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (49.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (45.6bn) -1–5 -$100M+ -15–50% 0–15%
Pharmaceuticals & Medical Research Large (45.4bn) 0 Aucune activité — 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.0bn) 0 Aucune activité — 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Aucune activité — 0–15%
Healthcare Services Large (43.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (41.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (40.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (39.2bn) 0 Aucune activité — 0–15%
Healthcare Services Large (38.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (38.3bn) 0 Aucune activité — 0–15%
US DexCom Inc (DXCM)
Healthcare Services Large (34.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (33.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (32.9bn) 0 Aucune activité — 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (32.4bn) 0 Aucune activité — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.2bn) -1–5 -$10M–$100M -0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (31.4bn) -1–5 -$100K–$1M -0–15% 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (31.0bn) -1–5 -$100M+ -0–15% 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (30.6bn) 0 Aucune activité — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (26.2bn) -6–10 -$100M+ -0–15% 15–50%
Healthcare Services Large (26.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (26.1bn) 0 Aucune activité — 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (25.1bn) 0 Aucune activité — 0–15%
Healthcare Services Large (24.7bn) 0 Aucune activité — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (21.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (21.7bn) -11–20 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (21.6bn) -6–10 -$10M–$100M -0–15% 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (21.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Aucune activité — 0–15%
Healthcare Services Large (18.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (18.2bn) 0 Aucune activité — 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Aucune activité — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (16.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (15.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (15.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (14.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (14.0bn) 0 Aucune activité — 0–15%
Healthcare Services Large (13.8bn) -1–5 -$100M+ -15–50% 0–15%
Pharmaceuticals & Medical Research Large (13.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (13.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (13.3bn) 0 Aucune activité — 0–15%
US Revvity Inc (RVTY)
Healthcare Services Large (13.3bn) 0 Aucune activité — 0–15%
US Penumbra Inc (PEN)
Healthcare Services Large (12.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (12.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (12.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (12.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (11.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (11.7bn) 0 Aucune activité — 0–15%
Healthcare Services Large (11.7bn) 0 Aucune activité — 0–15%
US Insulet Corp (PODD)
Healthcare Services Large (11.6bn) 1–5 $100K–$1M 0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (11.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US DaVita Inc (DVA)
Healthcare Services Large (11.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (11.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 1–5 $100K–$1M 0–15% 0–15%
US Glaukos Corp (GKOS)
Healthcare Services Large (11.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 Aucune activité — 15–50%
Healthcare Services Large (10.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (10.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.4bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Large (10.3bn) 0 Aucune activité — 0–15%